Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Drug Resistance

Yeast 'DNA damage sensor' provides chemotherapy resistance clue

Cancer Research UK scientists have been part of an international collaboration that has revealed the structure of a protein found in simple yeast cells and shown how it...

Scientists crack the code to tamoxifen resistance

Scientists crack the code to tamoxifen resistance

Newcastle scientist tells Minister of new cancer hope

Understanding how prostate cancers become resistant to treatment should bring about a new breed of potent anti-cancer drugs, a leading Cancer Research UK scientist will...

Unstable chromosomes cause resistance to cancer drugs

Cancer Research UK scientists have made an important step towards developing personalised bowel cancer treatment by identifying which tumours are more likely to become...

Tamoxifen resistance may be reversible

Resistance to breast cancer drug tamoxifen could be reversed by adding a simple chemical to the drug, say researchers.

Scientists discover how to beat resistance to standard leukaemia drug

Cancer Research UK-funded scientists at The Institute of Cancer Research (ICR) have revealed a technique to kill chronic myeloid leukaemia (CML) cells that have stopped...

UK study uncovers clue to cancer drug resistance

A new study jointly funded by Breakthrough Breast Cancer and Cancer Research UK has revealed how cancer cells carrying a faulty gene can become resistant to treatment.

Evolving ovarian cancer cells 'dodge' treatment with chemotherapy

Cancer Research UK scientists have discovered that the commonest type of ovarian cancer evolves at a startling rate, which may allow cancer cells to 'dodge' the current...

Toxin found to inhibit 'survival proteins' in cancer cells

A modified version of a toxin used to control fish populations might be able to block drug resistance in cancer cells.

Discovery 'significant step' in understanding leukaemia drug resistance

Scientists have pinpointed an enzyme responsible for breaking down and inactivating a key childhood leukaemia drug, which could help to explain why around 20 per cent of...